For comments, suggestions
Created with Raphaël 2.1.0 11.01.2018 Filing date 09.08.2019 Validation fee payment 31.12.2019 (A1) Patent application published 21.02.2022 AGEPI application filing date 30.04.2022 (T2) Translation of the validated European patent 11.01.2025 Valid until 03.05.2025 12.01.2026 Renewal fee to be paid until (grace period) 11.01.2038 Patent will expire on

Patent lapsed - still in grace period


(210)Number of the EPO application18702839
(220)Filing date of the EPO application2018.01.11
(80)EPO patent specification publication (B)EPB nr. 51/2021, 2021.12.22
(110)EPO patent number3570834
(11)Number of the documentMD 3570834 T2
(21)Number of the applicatione 2019 1311
(71)Name(s) of applicant(s), code of the countryAlkermes, Inc., US;
(72)Name(s) of inventor(s), code of the countryFULLER Nathan Oliver, US;
LOWE John A. III, US;
(73)Name(s) of owner(s), code of the countryALKERMES Inc., US;
(54)Title of the inventionBicyclic inhibitors of histone deacetylase
(13)Kind-of-document code T2
(51)International Patent Classification A61K 31/437 (2006.01.01); A61K 31/519 (2006.01.01); A61P 25/28 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2019.12.31
(49)Date of publication of the translation of the validated European patent specification2022.04.30
(30)Priority201762445022 P, 2017.01.11, US; 201762555298 P, 2017.09.07, US
(74)Patent attorney(Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova
(86)International applicationPCT/US2018/013260, 2018.01.11
(87)International publicationWO 2018/132531, 2018.07.19
Up
/Inventions/details/3570834